SCHEMBL6566899

SCHEMBL6566899

O=C(Nc1ccc(O)cc1O)NC1CC1c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
CXCR1 P25024 1/20 0.50
EPHX2 P34913 6/20 0.47
TLR2 O60603 3/20 0.46
TLR1 Q15399 3/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
IDH1 O75874 1/20 0.43
TRPV1 Q8NER1 2/20 0.43
DEGS1 O15121 1/20 0.43
KDM1A O60341 2/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6567627 0.82 CNR1 (0.59) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL6567565 0.75 CNR1 (0.71) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL6567546 0.75 CNR1 (0.64) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL6567236 0.74 CNR1 (0.62) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL9667225 0.74 SMN1; SMN2 (0.67) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL14049512 0.72 SMN1; SMN2 (0.70) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL8350625 0.72 SMN1; SMN2 (0.70) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL13923628 0.72 SMN1; SMN2 (0.70) CNR1SMN1; SMN2NPSR1EPHX2TLR2
SCHEMBL4350075 0.72 CXCR2 (0.71) SMN1; SMN2NPSR1CXCR1EPHX2CA1
SCHEMBL6568595 0.72 CNR1 (0.59) CNR1SMN1; SMN2NPSR1EPHX2TLR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed